Latest filing published 26 Feb 2016 for HOLOGIC INC, €282k.
Insider track record
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
David R. Lavance Jr.: trading record in brief
Filings by David R. Lavance Jr. span 3 companies, the busiest being Hologic Inc, Medi HUT Co Inc and Integrated Environmental Technologies, Ltd. We count 50 filings; the first trade dates from 26 January 2006 and the latest from 24 February 2016.
In open-market terms, that means 1 purchase worth €97k on one side and 16 sales worth €8.7M on the other. Taken together, the sales exceed the purchases by €8.6M. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Other entries cover 8 share grants and 21 option exercises. Since January 2016: no purchases and 1 sale on the market.
The record was last updated on 26 February 2016 with an option exercise (€282k) in Hologic Inc. The last purchase on record was published on 8 February 2007, which is 7,213 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. US insiders must file a Form 4 within two business days of a trade. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to David R. Lavance Jr.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 11,621 shares@ US$26.7443.7% of flowCommon StockSEC:0001127602-16-043589:0
- 11,621 shares@ US$34.5056.3% of flowCommon StockSEC:0001127602-16-043589:1
- 750,000 sharesCommon stock, par value $.001 per shareSEC:0001493152-16-007337:0
- 4,207 sharesCommon StockSEC:0001127602-16-036014:0
- 13,257 shares@ US$17.51Common StockSEC:0001127602-15-024482:0
- 15,822 shares@ US$20.01Common StockSEC:0001127602-15-024482:1
- 14,331 shares@ US$22.35Common StockSEC:0001127602-15-024482:2
- 4,000 shares@ US$23.64Common StockSEC:0001127602-15-024482:3
- 30,000 shares@ US$32.82Common StockSEC:0001127602-15-024482:4
- 20,000 shares@ US$32.82Common StockSEC:0001127602-15-024482:5
- 97,410 shares@ US$41.99Common StockSEC:0001127602-15-024482:6
- 21,600 shares@ US$32.82Common StockSEC:0001127602-15-024262:0
- 21,600 shares@ US$41.74Common StockSEC:0001127602-15-024262:1
- 28,400 shares@ US$32.82Common StockSEC:0001127602-15-024262:2
- 28,400 shares@ US$41.77Common StockSEC:0001127602-15-024262:3
- 3,613,250 shares0Common stock, par value $.001 per shareSEC:0001213900-15-002167:0
- 12,000 shares@ US$23.64Common StockSEC:0001127602-15-010596:0
- 12,000 shares@ US$32.12Common StockSEC:0001127602-15-010596:1
- 8,000 shares@ US$18.96Common StockSEC:0001127602-15-006343:0
- 8,000 shares@ US$30.32Common StockSEC:0001127602-15-006343:1
- 5,033 shares@ US$26.74Common StockSEC:0001127602-15-000652:0
- 5,500 shares@ US$21.49Common StockSEC:0001127602-14-011743:0
- 4,997 shares@ US$22.12Common StockSEC:0001127602-13-010472:0
- 12,774 shares@ US$18.82Common StockSEC:0001127602-13-010472:1
- 12,774 shares@ US$22.12Common StockSEC:0001127602-13-010472:2
25 of 45 declarations